Study Stopped
Interim analysis showed benefice of one therapy over the other one.
Restoring Masticatory Function to Treat Chronic Pain
MAP
3 other identifiers
interventional
77
1 country
2
Brief Summary
The primary endpoint will be the average change in pain score from baseline to the three- and six-month assessments. Efficacy will be demonstrated by superior pain relief with the active treatment compared with the placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2014
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2014
CompletedFirst Posted
Study publicly available on registry
May 21, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedResults Posted
Study results publicly available
April 22, 2020
CompletedApril 22, 2020
April 1, 2020
3.9 years
May 19, 2014
March 25, 2019
April 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Jaw-pain-Intensity (Affected Side)
Self-reported affected-side pain-intensity across the trial in a 0-10 visual analogue scale (VAS) (0=no pain, 10=worst possible pain). Higher values represent a worse outcome.
Baseline and 6-months
Secondary Outcomes (3)
Chewing Side
Baseline and 6-months
Change in Global Severity Index Scores (Symptom Checklist-90-Revised (SCL-90-R))
Baseline, 6-Months
Maximum Unassisted Jaw Opening
Baseline, 3- and 6-Months
Other Outcomes (20)
Headache-intensity
Baseline 3- and 6-Months
Number of Participants With Neuropathic Pain
Baseline, 6-Months
Handedness Preference
Baseline
- +17 more other outcomes
Study Arms (2)
Occlusal adjustment therapy
EXPERIMENTALOcclusal adjustment therapy consists of the elimination of premature tooth contacts during retruded jaw closure, and the reduction of the steeper lateral anterior guidance; the magnitude of this alteration will be estimated by the following equation: (right condylar path) × (left anterior guidance) = (left condylar path) × (right anterior guidance). A resin-composite, placed mainly in the canine tooth, can be used to increases the flatter lateral guidance on the habitual chewing side; overcorrection is expected to compensate for a masticatory preference on the opposite side to the handedness.
Placebo occlusal adjustment therapy
PLACEBO COMPARATORPlacebo occlusal adjustment will take place in a manner identical to the real adjustment. However, a specially fabricated inactive rotary instrument will be used, and no enamel will be removed.
Interventions
The first step consists of the elimination of premature tooth contacts during retruded jaw closure. The second step included reduction of the steeper lateral anterior guidance; the magnitude of this alteration will be estimated by the following equation: (right condylar path) × (left anterior guidance) = (left condylar path) × (right anterior guidance)
Placebo occlusal adjustment will take place in a manner identical to the real adjustment. However, a specially fabricated inactive rotary instrument will be used, and no enamel will be removed.
Eligibility Criteria
You may qualify if:
- Completely dentate (except for the third molars; including if they were treated before enrollment by conventional or implant-supported fixed prosthesis allowing similar potential comfortable chewing on both sides)
- Normal Angle Class I occlusion
- Self-reported pain-intensity scores from 4 to 9 in a 0-10 visual analogue scale (VAS) or numerical pain rating scale (NRS).
- Chronic (over 6 months) joint and/or muscle pain, according to diagnostic criteria for temporomandibular disorders (DC/TMD), for which they had requested therapy
You may not qualify if:
- Psychosis
- Major depression
- Substance abuse
- Cognitive impairment
- Addiction to morphine or derivates
- Litigation or asking for disability/retirement compensation for chronic pain
- Dental care professionals
- Orthodontic therapy during the last 2 years
- Patients with any pain that is more severe, in the same location as, or cannot be clearly distinguished from TMD pain
- Individuals for whom minimally invasive occlusal adjustment could not achieve occlusal equilibration, including: Over 2 mm of difference between the maximal intercuspal position and the centric occlusion or over 4 mm of difference between upper and lower archs (or over 2mm on at less one side) measured: between the mesial fosses of first upper premolars with respect the buccal cusps of the first lower premolars; and/or between the mesiopalatal cusp of the first upper molars respect to the central (mesial) fossae of the first lower molar.
- Severe periodontal disease with grade 3 mobility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universidad de Santiago de Compostela
Santiago de Compostela, A Coruña, Galicia, 15782, Spain
Complexo Hospitalario Universitario A Coruña
A Coruña, A Coruña. Galicia, 15006, Spain
Related Publications (1)
Santana-Mora U, Lopez-Cedrun J, Mora MJ, Otero XL, Santana-Penin U. Temporomandibular disorders: the habitual chewing side syndrome. PLoS One. 2013 Apr 8;8(4):e59980. doi: 10.1371/journal.pone.0059980. Print 2013.
PMID: 23593156BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Professor Urbano Santana Penín
- Organization
- University of Santiago de Compostela. A Coruña. SPAIN
Study Officials
- PRINCIPAL INVESTIGATOR
Urbano Santana-Penin, Prof
University of Santiago de Compostela
- STUDY CHAIR
Jose Lopez-Cedrun, Dr
University Hospital Complex of La Coruña
- STUDY DIRECTOR
Maria J Mora, Prof
University of Santiago de Compostela
- PRINCIPAL INVESTIGATOR
Urbano Santana-Mora, Dr
University of Santiago de Compostela
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
May 19, 2014
First Posted
May 21, 2014
Study Start
August 1, 2014
Primary Completion
June 15, 2018
Study Completion
June 15, 2018
Last Updated
April 22, 2020
Results First Posted
April 22, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The raw data of each participant, unidentifiable, will be accessible within 6 months after the publication of the manuscript and will be accessible for at least one year.
- Access Criteria
- Free access
A closed, certificate, database called OpenClinica allows access to members of the Data and Safety Monitoring Board. We expect to publish raw data in Sci Data. Figures from participant's mouth could be posted in a repository. The protocol will be attached as a supplementary appendix to the main manuscript